BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26437242)

  • 1. Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling.
    Charbonnier LM; Wang S; Georgiev P; Sefik E; Chatila TA
    Nat Immunol; 2015 Nov; 16(11):1162-73. PubMed ID: 26437242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct spatial and molecular features of notch pathway assembly in regulatory T cells.
    Perumalsamy LR; Marcel N; Kulkarni S; Radtke F; Sarin A
    Sci Signal; 2012 Jul; 5(234):ra53. PubMed ID: 22827997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells.
    Sekiya T; Kondo T; Shichita T; Morita R; Ichinose H; Yoshimura A
    J Exp Med; 2015 Sep; 212(10):1623-40. PubMed ID: 26304965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
    Lahl K; Loddenkemper C; Drouin C; Freyer J; Arnason J; Eberl G; Hamann A; Wagner H; Huehn J; Sparwasser T
    J Exp Med; 2007 Jan; 204(1):57-63. PubMed ID: 17200412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells.
    Campese AF; Grazioli P; Colantoni S; Anastasi E; Mecarozzi M; Checquolo S; De Luca G; Bellavia D; Frati L; Gulino A; Screpanti I
    Int Immunol; 2009 Jun; 21(6):727-43. PubMed ID: 19461123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR.
    Liu G; Burns S; Huang G; Boyd K; Proia RL; Flavell RA; Chi H
    Nat Immunol; 2009 Jul; 10(7):769-77. PubMed ID: 19483717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells.
    Samon JB; Champhekar A; Minter LM; Telfer JC; Miele L; Fauq A; Das P; Golde TE; Osborne BA
    Blood; 2008 Sep; 112(5):1813-21. PubMed ID: 18550850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cell development in the absence of functional Foxp3.
    Lin W; Haribhai D; Relland LM; Truong N; Carlson MR; Williams CB; Chatila TA
    Nat Immunol; 2007 Apr; 8(4):359-68. PubMed ID: 17273171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
    Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
    Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Foxo1-dependent transcriptional programs control T(reg) cell function.
    Ouyang W; Liao W; Luo CT; Yin N; Huse M; Kim MV; Peng M; Chan P; Ma Q; Mo Y; Meijer D; Zhao K; Rudensky AY; Atwal G; Zhang MQ; Li MO
    Nature; 2012 Nov; 491(7425):554-9. PubMed ID: 23135404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
    Koch MA; Tucker-Heard G; Perdue NR; Killebrew JR; Urdahl KB; Campbell DJ
    Nat Immunol; 2009 Jun; 10(6):595-602. PubMed ID: 19412181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
    Kornete M; Piccirillo CA
    Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
    Carson BD; Ziegler SF
    Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T(reg) stability: to be or not to be.
    Overacre AE; Vignali DA
    Curr Opin Immunol; 2016 Apr; 39():39-43. PubMed ID: 26774863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.